Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-10-017668
Filing Date
2010-03-31
Accepted
2010-03-31 15:05:46
Documents
1
Period of Report
2010-03-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3949
  Complete submission text file 0001104659-10-017668.txt   6040
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 7816221700
Atlas Venture Fund VII L P (Reporting) CIK: 0001346450 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 10718536